[1] Wu CC, Chen JS, Lin SH, et al. Experimental model of membranous nephropathy in mice: sequence of histological and biochemical events. Lab Anim. 2008; 42(3):350-359.
[2] Wu CC, Lu KC, Lin YF, et al. Pathogenic role of effector cells and immunoglobulins in cationic bovine serum albumin-induced membranous nephropathy. J Clin Immunol. 2012;32(1):138-149.
[3] Hu Z, Tang L, Chen Y. Experimental study of influence of yiqi huoxue serial recipes on basement membrane in membranous nephritis in rabbits. Zhongguo Zhong Xi Yi Jie He Za Zhi. 1999;19(2):96-99.
[4] 邱志权,王晶晶,腾晋莹,等.阳离子化牛血清白蛋白致大鼠慢性肾炎模型的研究[J].药物评价研究,2015,38(5): 484-490.
[5] Border WA, Ward HJ, Kamil ES, et al. Induction of membranous nephropathy in rabbits by administration of an exogenous cationic antigen. J Clin Invest. 1982; 69(2):451-461.
[6] Wu CC, Chen JS, Chen SJ, et al. Kinetics of adaptive immunity to cationic bovine serum albumin-induced membranous nephropathy.Kidney Int. 2007;72(7): 831-840.
[7] Li TT, Zhang XH, Jing JF, et al. Artemisinin analogue SM934 ameliorates the proteinuria and renal fibrosis in rat experimental membranous nephropathy. Acta Pharmacol Sin. 2015;36(2):188-199.
[8] Beck LH Jr, Salant DJ. Membranous nephropathy: from models to man. J Clin Invest. 2014;124(6): 2307-2314.
[9] Borza DB, Zhang JJ, Beck LH Jr, et al. Mouse models of membranous nephropathy: the road less travelled by. Am J Clin Exp Immunol. 2013;2(2):135-145.
[10] Kimura J, Ichii O, Otsuka S, et al. Close relations between podocyte injuries and membranous proliferative glomerulonephritis in autoimmune murine models. Am J Nephrol. 2013;38(1):27-38.
[11] Debiec H, Lefeu F, Kemper MJ, et al. Early-childhood membranous nephropathy due to cationic bovine serum albumin. N Engl J Med. 2011;364(22): 2101-2110.
[12] Chen JS, Chen A, Chang LC, et al. Mouse model of membranous nephropathy induced by cationic bovine serum albumin: antigen dose-response relations and strain differences. Nephrol Dial Transplant. 2004; 19(11): 2721-2728.
[13] Liu ZZ. Induction of membranous glomerulonephritis with crescent formation by administration of exogenous cationic antigen in rabbits.Zhonghua Bing Li Xue Za Zhi. 1988;17(4):277-279.
[14] 梁静,孙兴旺,曹灵,等.不同剂量阳离子化牛血清白蛋白对膜性肾病大鼠造模的影响[J].中国组织工程研究与临床康复,2008,12(17):7322-7325.
[15] Zhuang YZ, Wei LF, Yu YH, et al. The expression and significance of nephrin in hepatitis B virus-associated membranous nephropathy.Zhonghua Nei Ke Za Zhi. 2011;50(9):766-770.
[16] Nakatsue T, Koike H, Han GD, et al. Nephrin and podocin dissociate at the onset of proteinuria in experimental membranous nephropathy. Kidney Int. 2005;67(6):2239-2253.
[17] Kim BK, Hong HK, Kim JH, et al. Differential expression of nephrin in acquired human proteinuric diseases. Am J Kidney Dis. 2002;40(5):964-973.
[18] Huh W, Kim DJ, Kim MK, et al. Expression of nephrin in acquired human glomerular disease. Nephrol Dial Transplant. 2002;17(3):478-484.
[19] Doublier S, Ruotsalainen V, Salvidio G, et al. Nephrin redistribution on podocytes is a potential mechanism for proteinuria in patients with primary acquired nephrotic syndrome. Am J Pathol. 2001;158(5): 1723-1731.
[20] 庄永泽,魏丽芳,余英豪,等.乙型肝炎病毒相关性膜性肾病中nephrin的表达及意义[J].中华内科杂志,2011,50(9): 766-770.
[21] Agrawal V, Prasad N, Jain M, et al. Reduced podocin expression in minimal change disease and focal segmental glomerulosclerosis is related to the level of proteinuria. Clin Exp Nephrol. 2013;17(6):811-818.
[22] Gorriz JL, Martinez-Castelao A. Proteinuria: detection and role in native renal disease progression. Transplant Rev (Orlando). 2012;26(1):3-13.
[23] Kobayashi R, Kamiie J, Yasuno K, et al. Expression of nephrin, podocin, α-actinin-4 and α3-integrin in canine renal glomeruli. J Comp Pathol. 2011;145(2-3): 220-225.
[24] 刘海泉,范亚平,达展云,等. 膜性肾病肾活检组织中nephrin和podocin表达改变及其意义[J].肾脏病与透析肾移植杂志,2009,18(4):318-321,328.
[25] Nakatsue T, Koike H, Han GD, et al. Nephrin and podocin dissociate at the onset of proteinuria in experimental membranous nephropathy. Kidney Int. 2005;67(6):2239-2253.
[26] 达展云,范亚平,沈良兰,等.Nephrin和Podocin在3种膜性肾病表达中的差异及其意义[J].中国现代医学杂志, 2009, 19(15):2381-2385.
[27] Schmid H, Henger A, Cohen CD, et al. Gene expression profiles of podocyte-associated molecules as diagnostic markers in acquired proteinuric diseases. J Am Soc Nephrol. 2003;14(11):2958-2966.
[28] 任美芳. 益肾通络方对膜性肾病大鼠的肾保护作用以及对肾组织Nephrin mRNA、Podocin mRNA 表达的影响[D].石家庄:河北医科大学, 2013.
[29] Stratakis S, Stylianou K, Petrakis I, et al. Rapamycin ameliorates proteinuria and restores nephrin and podocin expression in experimental membranous nephropathy. Clin Dev Immunol. 2013;2013:941893.
[30] 冯振伟,陈圳炜,杨陈,等.方格星虫提取物对膜性肾病模型的治疗作用及机制初探[J].中国中西医结合肾病杂志, 2012,13(3):219-222.
[31] 宋立群,李慧,马艳春,等.虫草益肾颗粒对膜性肾病大鼠生化指标及肾组织形态学影响的研究[J].中医药学报, 2014, 42(3): 23-25.
[32] 王慧,王净,李静,等.膜性肾病小鼠模型的建立与鉴定[J].细胞与分子免疫学杂志,2013,29(2):197-199. |